Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for SYMLIN
- Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot Study
- Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease
- A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus
- Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery
- Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
- Effectiveness Study of Pramlintide to Treat Post-Transplant Diabetes Mellitus
- Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus
- The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes
- Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
- Pramlintide in Adolescents With Type 1 Diabetes
- Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin
- Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DM
- Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes
- A Pilot Study of Continuous Subcutaneous Pramlintide Infusion Therapy in Patients With Type 1 Diabetes
- A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes
- A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects
- A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus
- A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes
- An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes
- A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects
Clinical trials list
click for details